NCT05653141 (CogStroke) is a clinical trial in First-ever Ischemic Stroke, sponsored by Roza Umarova.

Who is sponsoring NCT05653141?

NCT05653141 is sponsored by Roza Umarova.

What condition does NCT05653141 study?

NCT05653141 studies First-ever Ischemic Stroke, Cognitive Performance.

Is NCT05653141 still recruiting?

NCT05653141 is currently active, enrolled. Last updated 13 November 2024.

Last reviewed 2024-11-13 · How we verify

NCT05653141: CogStroke

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Post-stroke Cognitive Impairment

Active, enrolled Last updated 13 November 2024

What this trial tests

trial in First-ever Ischemic Stroke in 335 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

17 December 2020

Primary endpoint
31 October 2026

31 October 2026

Quick facts

Lead sponsor	Roza Umarova
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	335
Start date	17 December 2020
Primary completion	31 October 2026
Estimated completion	31 October 2026
Sites	1 location across Switzerland

Conditions studied

First-ever Ischemic Stroke — all drugs for First-ever Ischemic Stroke →
Cognitive Performance — all drugs for Cognitive Performance →

Sponsor

Roza Umarova

Who can join

18 and older, any sex, with First-ever Ischemic Stroke or Cognitive Performance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Present study aims to track the post-stroke cognitive trajectories and to investigate its inter-individual variability.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Improving diagnostic accuracy of the Montreal Cognitive Assessment to identify post-stroke cognitive impairment.
Gallucci L, Sperber C, Monsch AU, Klöppel S, et al · · 2024 · cited 8× · PMID 39209968 · DOI 10.1038/s41598-024-71184-x

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05653141 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Roza Umarova
Last refreshed: 13 November 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05653141.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing